Menu

Press Releases

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for Adult and Pediatric Patients with Classical Hodgkin Lymphoma (cHL) Refractory to Treatment, or Who Have Relapsed After Three or More Prior Lines of Therapy

Only Anti-PD-1 Therapy Approved for the Treatment of Patients with Difficult-to-Treat cHL Regardless of Prior Stem Cell Transplantation or Use of Brentuximab Vedotin KENILWORTH, N.J. March 14, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), the […]

Merck Provides Update on Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) in Previously Treated Advanced Microsatellite Instability-High Cancer

KENILWORTH, N.J. March 14, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has extended the action date for the supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 therapy, for previously treated patients with advanced microsatellite instability-high (MSI-H) […]

Animal Study Shows Harmful Effects of Secondhand Smoke Even Before Pregnancy

Findings raise caution for women of childbearing age DURHAM, N.C. March 13, 2017 – Exposure to second-hand tobacco smoke — even before conception — appears to have a lingering impact that can later impair the brain development of a fetus, researchers at Duke Health report. Using rats in experiments carefully designed to mimic the second-hand […]

Pokémon Go Appears to Encourage Sedentary People to Get Up and Go

Small study shows that the interactive game prompted people to walk more steps a day DURHAM, N.C. March 9, 2017 – The Pokémon Go craze that spurred millions of people to collect virtual monsters via a smart phone app might have also had a health benefit by encouraging people to get up and walk. A […]

New Study Results May Lead to a New Standard of Care for in Vitro Fertilization Treatment

, , ,

Oral Dydrogesterone has the potential to become new treatment of choice for an estimated 1.5 million women worldwide who undergo IVF treatment each year (1, 2) ABBOTT PARK, Ill., March 8, 2017 /PRNewswire/ — New study results published in Human Reproduction could pave the way for an additional treatment option for the estimated 1.5 million […]

Merck and Pfizer Announce U.S. FDA and EMA Filing Acceptances of Three Marketing Applications for Ertugliflozin-Containing Medicines for Adults with Type 2 Diabetes

Investigational SGLT2 Inhibitor Submitted as Monotherapy and in Fixed-Dose Combinations with JANUVIA ® (sitagliptin) or Metformin KENILWORTH, N.J. & NEW YORK – March 6, 2017 –(BUSINESS WIRE)–Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Pfizer Inc. (NYSE:FE), today announced that the U.S. Food and Drug Administration (FDA) has accepted for review […]

New Head-to-Head Data Shows Significantly Higher Response Rates for Lilly’s Taltz® (ixekizumab) Compared to Stelara® (ustekinumab) in Patients with Moderate-to-Severe Plaque Psoriasis

Lilly to present head-to-head 24-week data comparing the efficacy and safety of Taltz and Stelara for the treatment of moderate-to-severe plaque psoriasis INDIANAPOLIS, March 4, 2017 /CNW/ — Eli Lilly and Company (NYSE: LLY) announced today that patients with moderate-to-severe plaque psoriasis treated with Taltz® (ixekizumab) demonstrated superior efficacy at 24 weeks compared to patients […]

Lilly Diabetes Becomes ‘Official Diabetes Health Partner of NASCAR®’

New Relationship Builds on Partnership with Roush Fenway Racing™ DAYTONA BEACH, Fla., March 3, 2017 /PRNewswire/ — NASCAR® and Lilly Diabetes announced today that Lilly is expanding its involvement in NASCAR with a multi-year official partnership with the sanctioning body. The new collaboration designates Lilly Diabetes as the “Official Diabetes Health Partner of NASCAR.” The […]

Lilly Announces Changes in Senior Management

Fionnuala Walsh retiring, Johna Norton promoted; Bart Peterson leaving to pursue external interests INDIANAPOLIS, March 2, 2017 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced changes in its executive committee. Johna Norton will be promoted to senior vice president of global quality April 1, replacing Fionnuala Walsh, who is retiring April 15 after […]

«‹ 66 67 68 69›»